OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35
Showing 26-50 of 35 citing articles:
Contribution of alpha‐synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI
Samir Abu‐Rumeileh, G Arajyan, Eric M. Reiman, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 10, pp. 7411-7419
Open Access | Times Cited: 2
Samir Abu‐Rumeileh, G Arajyan, Eric M. Reiman, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 10, pp. 7411-7419
Open Access | Times Cited: 2
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature
Tina Milos, Barbara Vuić, N. Balic, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Closed Access | Times Cited: 2
Tina Milos, Barbara Vuić, N. Balic, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Closed Access | Times Cited: 2
Self‐ and study partner–reported cognitive decline in older adults without dementia: The role of α‐synuclein and amyloid biomarkers in the Alzheimer's Disease Neuroimaging Initiative
Kelsey R. Thomas, Katherine J. Bangen, Lindsay J. Rotblatt, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 2
Kelsey R. Thomas, Katherine J. Bangen, Lindsay J. Rotblatt, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 2
Misfolded alpha synuclein co-occurrence with Alzheimer's disease proteinopathy
Erin M. Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Erin M. Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer’s disease
Klara Gawor, Sandra O. Tomé, Rik Vandenberghe, et al.
Brain Communications (2024) Vol. 6, Iss. 6
Open Access | Times Cited: 2
Klara Gawor, Sandra O. Tomé, Rik Vandenberghe, et al.
Brain Communications (2024) Vol. 6, Iss. 6
Open Access | Times Cited: 2
Amygdala-predominant α-synuclein pathology exacerbates hippocampal neuron loss in Alzheimer's disease
Klara Gawor, Sandra O. Tomé, Rik Vandenberghe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Klara Gawor, Sandra O. Tomé, Rik Vandenberghe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Research advancement in fluid biomarkers for Parkinson’s disease
Lorenzo Gaetani, Federico Paolini Paoletti, Alessandro Mechelli, et al.
Expert Review of Molecular Diagnostics (2024)
Closed Access | Times Cited: 1
Lorenzo Gaetani, Federico Paolini Paoletti, Alessandro Mechelli, et al.
Expert Review of Molecular Diagnostics (2024)
Closed Access | Times Cited: 1
Updates in Fluid, Tissue, and Imaging Biomarkers for Dementia with Lewy Bodies and Implications for Biologically Based Disease Definitions
Samantha K. Holden
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 6, pp. 189-201
Closed Access
Samantha K. Holden
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 6, pp. 189-201
Closed Access
Rare disorders as models for de(re)generation: is the V-ATPase a clue to understanding tauopathies?
Tommaso Nicoletti
European Neurology (2024), pp. 1-3
Closed Access
Tommaso Nicoletti
European Neurology (2024), pp. 1-3
Closed Access
α-Synuclein seeding activity and progression in sporadic and genetic forms of Parkinson's disease in the Parkinson's Progression Markers Initiative cohort
Jackson G. Schumacher, Xinyuan Zhang, Eric A. Macklin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Jackson G. Schumacher, Xinyuan Zhang, Eric A. Macklin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease
Jaime Kulisevsky, Irene Litvan, Daniel Weintraub, et al.
Movement Disorders Clinical Practice (2024)
Closed Access
Jaime Kulisevsky, Irene Litvan, Daniel Weintraub, et al.
Movement Disorders Clinical Practice (2024)
Closed Access
